These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 37144832)
21. Confirming Multiplex RT-qPCR Use in COVID-19 with Next-Generation Sequencing: Strategies for Epidemiological Advantage. Carpenter RE; Tamrakar V; Chahar H; Vine T; Sharma R Glob Health Epidemiol Genom; 2022; 2022():2270965. PubMed ID: 35950011 [TBL] [Abstract][Full Text] [Related]
22. Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences. O'Toole Á; Pybus OG; Abram ME; Kelly EJ; Rambaut A BMC Genomics; 2022 Feb; 23(1):121. PubMed ID: 35148677 [TBL] [Abstract][Full Text] [Related]
23. A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic. Singh P; Negi SS; Bhargava A; Kolla VP; Arora RD Arch Med Res; 2022 Sep; 53(6):574-584. PubMed ID: 36123226 [TBL] [Abstract][Full Text] [Related]
24. A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern. Bezerra MF; Machado LC; De Carvalho VDCV; Docena C; Brandão-Filho SP; Ayres CFJ; Paiva MHS; Wallau GL Infect Genet Evol; 2021 Aug; 92():104910. PubMed ID: 33975021 [TBL] [Abstract][Full Text] [Related]
25. Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy. Dorlass EG; Lourenço KL; Magalhães RDM; Sato H; Fiorini A; Peixoto R; Coelho HP; Telezynski BL; Scagion GP; Ometto T; Thomazelli LM; Oliveira DBL; Fernandes AP; Durigon EL; Fonseca FG; Teixeira SMR Genomics; 2021 Nov; 113(6):4109-4115. PubMed ID: 34718131 [TBL] [Abstract][Full Text] [Related]
26. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern. Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323 [TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 Variants Identification; A Fast and Affordable Strategy Based on Partial S-Gene Targeted PCR Sequencing. Martínez-Murcia A; Garcia-Sirera A; Navarro A; Pérez L Viruses; 2022 Nov; 14(11):. PubMed ID: 36423197 [TBL] [Abstract][Full Text] [Related]
28. A pyrosequencing protocol for rapid identification of SARS-CoV-2 variants. Allen RA; Williams CL; Penrod Y; McCloskey C; Carpenter-Azevedo K; Huard RC; King E; Terence Dunn S J Med Virol; 2022 Aug; 94(8):3661-3668. PubMed ID: 35416308 [TBL] [Abstract][Full Text] [Related]
29. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022. Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830 [TBL] [Abstract][Full Text] [Related]
30. Use of Sanger protocols to identify variants of concern, key mutations and track evolution of SARS-CoV-2. Cabral GB; Ahagon CM; de Souza Guimarães PM; Silva Lopez-Lopes GI; Hussein IM; Cilli A; de Jesus Alves I; Coelho Bombonatte AG; do Carmo Sampaio Tavares Timenetsky M; da Silva Santos JH; de Oliveira Santos KC; Dos Santos FCP; de Macedo Brígido LF J Virol Methods; 2022 Feb; 300():114422. PubMed ID: 34915086 [TBL] [Abstract][Full Text] [Related]
31. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology. Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499 [TBL] [Abstract][Full Text] [Related]
32. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA. Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143 [TBL] [Abstract][Full Text] [Related]
33. Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics. Oh C; Sashittal P; Zhou A; Wang L; El-Kebir M; Nguyen TH Appl Environ Microbiol; 2022 Apr; 88(7):e0228921. PubMed ID: 35285246 [TBL] [Abstract][Full Text] [Related]
34. HiSpike Method for High-Throughput Cost Effective Sequencing of the SARS-CoV-2 Spike Gene. Fass E; Zizelski Valenci G; Rubinstein M; Freidlin PJ; Rosencwaig S; Kutikov I; Werner R; Ben-Tovim N; Bucris E; Erster O; Zuckerman NS; Mor O; Mendelson E; Dveyrin Z; Rorman E; Nissan I Front Med (Lausanne); 2021; 8():798130. PubMed ID: 35087848 [TBL] [Abstract][Full Text] [Related]
35. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022. Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547 [TBL] [Abstract][Full Text] [Related]
36. Development, testing and validation of a SARS-CoV-2 multiplex panel for detection of the five major variants of concern on a portable PCR platform. Stanhope BJ; Peterson B; Knight B; Decadiz RN; Pan R; Davis P; Fraser A; Nuth M; vanWestrienen J; Wendlandt E; Goodwin B; Myers C; Stone J; Sozhamannan S Front Public Health; 2022; 10():1042647. PubMed ID: 36590003 [TBL] [Abstract][Full Text] [Related]
37. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays. Borillo GA; Kagan RM; Marlowe EM Front Cell Infect Microbiol; 2022; 12():894613. PubMed ID: 35619652 [TBL] [Abstract][Full Text] [Related]
38. Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysis. Sberna G; Fabeni L; Berno G; Carletti F; Specchiarello E; Colavita F; Meschi S; Matusali G; Garbuglia AR; Bordi L; Lalle E Int J Infect Dis; 2022 Sep; 122():401-404. PubMed ID: 35760381 [TBL] [Abstract][Full Text] [Related]
39. In Silico Evaluation of SARS-CoV-2 K417N, L452R, and E484K Detection Assays Against Omicron Variants. Sayan M; Arikan A; Isbilen M New Microbiol; 2023 May; 46(2):133-140. PubMed ID: 37247233 [TBL] [Abstract][Full Text] [Related]
40. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern. Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]